These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33422625)

  • 1. Biologic treatment outcomes in mucous membrane pemphigoid: A systematic review.
    Lytvyn Y; Rahat S; Mufti A; Witol A; Bagit A; Sachdeva M; Yeung J
    J Am Acad Dermatol; 2022 Jul; 87(1):110-120. PubMed ID: 33422625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review on efficacy, safety and treatment durability of intravenous immunoglobulin in autoimmune bullous dermatoses: Special focus on indication and combination therapy.
    Kianfar N; Dasdar S; Daneshpazhooh M; Aryanian Z; Goodarzi A
    Exp Dermatol; 2023 Jul; 32(7):934-944. PubMed ID: 37150538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current medical treatment of ocular mucous membrane pemphigoid.
    Sobolewska B; Deuter C; Zierhut M
    Ocul Surf; 2013 Oct; 11(4):259-66. PubMed ID: 24112229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients.
    Bohelay G; Alexandre M; Le Roux-Villet C; Sitbon I; Doan S; Soued I; Shourick J; Rousset L; Mellottee B; Heller M; Lièvre N; Zumelzu C; Morin F; Grootenboer-Mignot S; Gabison E; Caux F; Prost-Squarcioni C; Musette P
    Front Immunol; 2022; 13():915205. PubMed ID: 35844526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies.
    Letko E; Miserocchi E; Daoud YJ; Christen W; Foster CS; Ahmed AR
    Clin Immunol; 2004 Jun; 111(3):303-10. PubMed ID: 15183151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP).
    Maley A; Warren M; Haberman I; Swerlick R; Kharod-Dholakia B; Feldman R
    J Am Acad Dermatol; 2016 May; 74(5):835-40. PubMed ID: 26936298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of the long-term therapeutic effectiveness and safety profile of rituximab in the treatment of mucous membrane pemphigoid in a German university center between 2008 and 2019.
    Bamberger F; König IR; Gola D; Zillikens D; Sadik CD
    Front Immunol; 2023; 14():1180150. PubMed ID: 37143653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pemphigus and mucous membrane pemphigoid: An update from diagnosis to therapy.
    Buonavoglia A; Leone P; Dammacco R; Di Lernia G; Petruzzi M; Bonamonte D; Vacca A; Racanelli V; Dammacco F
    Autoimmun Rev; 2019 Apr; 18(4):349-358. PubMed ID: 30738958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ocular mucous membrane pemphigoid: novel treatment strategies.
    Jabbour S; Phylactou M; Ahmad S
    Curr Opin Allergy Clin Immunol; 2021 Oct; 21(5):486-492. PubMed ID: 34269741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of intravenous immunoglobulin therapy versus conventional immunosuppressive therapy in patients with mucous membrane pemphigoid: a preliminary study.
    Daoud Y; Amin KG; Mohan K; Ahmed AR
    Ann Pharmacother; 2005 Dec; 39(12):2003-8. PubMed ID: 16264064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. World Workshop on Oral Medicine VI: a systematic review of the treatment of mucous membrane pemphigoid.
    Taylor J; McMillan R; Shephard M; Setterfield J; Ahmed R; Carrozzo M; Grando S; Mignogna M; Kuten-Shorrer M; Musbah T; Elia A; McGowan R; Kerr AR; Greenberg MS; Hodgson T; Sirois D
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Aug; 120(2):161-71.e20. PubMed ID: 25953640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of rituximab in the treatment of mucous membrane pemphigoid: An analytic review.
    Farooq MM; Miloslavsky EM; Konikov N; Ahmed AR
    Autoimmun Rev; 2022 Aug; 21(8):103119. PubMed ID: 35688385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cicatricial pemphigoid, mucous membrane pemphigoid].
    Doffoel-Hantz V; Robert PY; Bédane C
    Presse Med; 2010 Oct; 39(10):1049-57. PubMed ID: 20850262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Critical analysis of the use of rituximab in mucous membrane pemphigoid: a review of the literature.
    Shetty S; Ahmed AR
    J Am Acad Dermatol; 2013 Mar; 68(3):499-506. PubMed ID: 23200198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. World Workshop of Oral Medicine VII: A systematic review of immunobiologic therapy for oral manifestations of pemphigoid and pemphigus.
    Mays JW; Carey BP; Posey R; Gueiros LA; France K; Setterfield J; Woo SB; Sollecito TP; Culton D; Payne AS; Greenberg MS; De Rossi S
    Oral Dis; 2019 Jun; 25 Suppl 1(Suppl 1):111-121. PubMed ID: 31140696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab preserves vision in ocular mucous membrane pemphigoid.
    Rübsam A; Stefaniak R; Worm M; Pleyer U
    Expert Opin Biol Ther; 2015 Jul; 15(7):927-33. PubMed ID: 25966960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review.
    Cao P; Xu W; Zhang L
    Front Immunol; 2022; 13():928621. PubMed ID: 35769474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mucous membrane pemphigoid: a review].
    Bédane C; Doffoel Hantz V
    Ann Dermatol Venereol; 2011 Mar; 138(3):201-8. PubMed ID: 21397149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of rituximab in patients with mucous membrane pemphigoid.
    Amir Dastmalchi D; Moslemkhani S; Bayat M; Balighi K; Abedini R; Mahmoudi H; Daneshpazhooh M
    J Dermatolog Treat; 2022 Mar; 33(2):1084-1090. PubMed ID: 32723108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Childhood ocular mucous membrane pemphigoid successfully treated with rituximab.
    Flores-Climente V; Rozas-Muñoz E; Martínez-Grau A; Aucouturier F; Luna S; Baselga E
    Pediatr Dermatol; 2019 Nov; 36(6):984-985. PubMed ID: 31448438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.